![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: COQ6 |
Gene summary for COQ6 |
![]() |
Gene information | Species | Human | Gene symbol | COQ6 | Gene ID | 51004 |
Gene name | coenzyme Q6, monooxygenase | |
Gene Alias | CGI-10 | |
Cytomap | 14q24.3 | |
Gene Type | protein-coding | GO ID | GO:0006743 | UniProtAcc | Q9Y2Z9 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
51004 | COQ6 | LZE4T | Human | Esophagus | ESCC | 5.52e-06 | 2.27e-01 | 0.0811 |
51004 | COQ6 | LZE8T | Human | Esophagus | ESCC | 3.13e-05 | 1.65e-01 | 0.067 |
51004 | COQ6 | LZE20T | Human | Esophagus | ESCC | 7.19e-04 | 1.17e-01 | 0.0662 |
51004 | COQ6 | LZE22T | Human | Esophagus | ESCC | 3.68e-07 | 3.90e-01 | 0.068 |
51004 | COQ6 | LZE24T | Human | Esophagus | ESCC | 4.35e-17 | 4.02e-01 | 0.0596 |
51004 | COQ6 | LZE6T | Human | Esophagus | ESCC | 6.91e-04 | 1.79e-01 | 0.0845 |
51004 | COQ6 | P1T-E | Human | Esophagus | ESCC | 3.86e-02 | 1.60e-01 | 0.0875 |
51004 | COQ6 | P2T-E | Human | Esophagus | ESCC | 5.30e-21 | 2.72e-01 | 0.1177 |
51004 | COQ6 | P4T-E | Human | Esophagus | ESCC | 5.69e-19 | 4.13e-01 | 0.1323 |
51004 | COQ6 | P5T-E | Human | Esophagus | ESCC | 2.03e-09 | 1.91e-01 | 0.1327 |
51004 | COQ6 | P8T-E | Human | Esophagus | ESCC | 1.25e-26 | 3.86e-01 | 0.0889 |
51004 | COQ6 | P9T-E | Human | Esophagus | ESCC | 7.94e-03 | 9.72e-02 | 0.1131 |
51004 | COQ6 | P10T-E | Human | Esophagus | ESCC | 1.75e-25 | 3.67e-01 | 0.116 |
51004 | COQ6 | P11T-E | Human | Esophagus | ESCC | 1.85e-10 | 3.51e-01 | 0.1426 |
51004 | COQ6 | P12T-E | Human | Esophagus | ESCC | 5.95e-29 | 4.78e-01 | 0.1122 |
51004 | COQ6 | P15T-E | Human | Esophagus | ESCC | 4.58e-23 | 4.61e-01 | 0.1149 |
51004 | COQ6 | P16T-E | Human | Esophagus | ESCC | 7.16e-26 | 4.50e-01 | 0.1153 |
51004 | COQ6 | P17T-E | Human | Esophagus | ESCC | 8.34e-07 | 3.19e-01 | 0.1278 |
51004 | COQ6 | P19T-E | Human | Esophagus | ESCC | 7.49e-08 | 4.94e-01 | 0.1662 |
51004 | COQ6 | P20T-E | Human | Esophagus | ESCC | 4.92e-15 | 3.17e-01 | 0.1124 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:190166112 | Esophagus | ESCC | quinone metabolic process | 34/8552 | 40/18723 | 3.00e-07 | 4.27e-06 | 34 |
GO:00067432 | Esophagus | ESCC | ubiquinone metabolic process | 17/8552 | 19/18723 | 9.02e-05 | 6.50e-04 | 17 |
GO:00067442 | Esophagus | ESCC | ubiquinone biosynthetic process | 15/8552 | 17/18723 | 3.48e-04 | 2.03e-03 | 15 |
GO:19016632 | Esophagus | ESCC | quinone biosynthetic process | 15/8552 | 17/18723 | 3.48e-04 | 2.03e-03 | 15 |
GO:00421805 | Esophagus | ESCC | cellular ketone metabolic process | 120/8552 | 211/18723 | 6.70e-04 | 3.55e-03 | 120 |
GO:19016613 | Oral cavity | OSCC | quinone metabolic process | 32/7305 | 40/18723 | 1.40e-07 | 2.34e-06 | 32 |
GO:00421804 | Oral cavity | OSCC | cellular ketone metabolic process | 111/7305 | 211/18723 | 3.94e-05 | 3.45e-04 | 111 |
GO:0006743 | Oral cavity | OSCC | ubiquinone metabolic process | 16/7305 | 19/18723 | 7.05e-05 | 5.60e-04 | 16 |
GO:0006744 | Oral cavity | OSCC | ubiquinone biosynthetic process | 14/7305 | 17/18723 | 3.31e-04 | 2.04e-03 | 14 |
GO:1901663 | Oral cavity | OSCC | quinone biosynthetic process | 14/7305 | 17/18723 | 3.31e-04 | 2.04e-03 | 14 |
GO:0042181 | Oral cavity | OSCC | ketone biosynthetic process | 26/7305 | 43/18723 | 3.55e-03 | 1.49e-02 | 26 |
GO:190166111 | Oral cavity | LP | quinone metabolic process | 24/4623 | 40/18723 | 2.17e-06 | 4.85e-05 | 24 |
GO:00067441 | Oral cavity | LP | ubiquinone biosynthetic process | 10/4623 | 17/18723 | 2.80e-03 | 1.95e-02 | 10 |
GO:19016631 | Oral cavity | LP | quinone biosynthetic process | 10/4623 | 17/18723 | 2.80e-03 | 1.95e-02 | 10 |
GO:004218012 | Oral cavity | LP | cellular ketone metabolic process | 70/4623 | 211/18723 | 3.29e-03 | 2.21e-02 | 70 |
GO:00421811 | Oral cavity | LP | ketone biosynthetic process | 19/4623 | 43/18723 | 4.04e-03 | 2.61e-02 | 19 |
GO:00067431 | Oral cavity | LP | ubiquinone metabolic process | 10/4623 | 19/18723 | 8.09e-03 | 4.40e-02 | 10 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa012405 | Esophagus | ESCC | Biosynthesis of cofactors | 97/4205 | 153/8465 | 3.88e-04 | 1.35e-03 | 6.94e-04 | 97 |
hsa0124012 | Esophagus | ESCC | Biosynthesis of cofactors | 97/4205 | 153/8465 | 3.88e-04 | 1.35e-03 | 6.94e-04 | 97 |
hsa012404 | Oral cavity | OSCC | Biosynthesis of cofactors | 88/3704 | 153/8465 | 3.84e-04 | 1.20e-03 | 6.12e-04 | 88 |
hsa0124011 | Oral cavity | OSCC | Biosynthesis of cofactors | 88/3704 | 153/8465 | 3.84e-04 | 1.20e-03 | 6.12e-04 | 88 |
hsa001302 | Oral cavity | LP | Ubiquinone and other terpenoid-quinone biosynthesis | 8/2418 | 11/8465 | 3.03e-03 | 1.29e-02 | 8.35e-03 | 8 |
hsa0124021 | Oral cavity | LP | Biosynthesis of cofactors | 57/2418 | 153/8465 | 1.17e-02 | 3.91e-02 | 2.52e-02 | 57 |
hsa001303 | Oral cavity | LP | Ubiquinone and other terpenoid-quinone biosynthesis | 8/2418 | 11/8465 | 3.03e-03 | 1.29e-02 | 8.35e-03 | 8 |
hsa0124031 | Oral cavity | LP | Biosynthesis of cofactors | 57/2418 | 153/8465 | 1.17e-02 | 3.91e-02 | 2.52e-02 | 57 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
COQ6 | SNV | Missense_Mutation | c.518G>A | p.Arg173His | p.R173H | Q9Y2Z9 | protein_coding | deleterious(0.04) | benign(0) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
COQ6 | SNV | Missense_Mutation | novel | c.1277N>A | p.Ala426Asp | p.A426D | Q9Y2Z9 | protein_coding | deleterious(0) | probably_damaging(0.979) | TCGA-AJ-A3BH-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
COQ6 | SNV | Missense_Mutation | novel | c.600N>T | p.Gln200His | p.Q200H | Q9Y2Z9 | protein_coding | tolerated(0.15) | benign(0.012) | TCGA-AJ-A3EK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | CR |
COQ6 | SNV | Missense_Mutation | rs371260604 | c.782N>T | p.Pro261Leu | p.P261L | Q9Y2Z9 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-AJ-A3OJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | CR |
COQ6 | SNV | Missense_Mutation | novel | c.841C>A | p.Leu281Ile | p.L281I | Q9Y2Z9 | protein_coding | deleterious(0) | probably_damaging(0.991) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
COQ6 | SNV | Missense_Mutation | novel | c.231N>T | p.Glu77Asp | p.E77D | Q9Y2Z9 | protein_coding | tolerated(0.63) | benign(0) | TCGA-AP-A1E0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | SD |
COQ6 | SNV | Missense_Mutation | rs377529207 | c.367G>A | p.Ala123Thr | p.A123T | Q9Y2Z9 | protein_coding | deleterious(0.05) | benign(0.044) | TCGA-AX-A1CE-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unspecific | Paclitaxel | SD |
COQ6 | SNV | Missense_Mutation | c.496C>A | p.Leu166Ile | p.L166I | Q9Y2Z9 | protein_coding | tolerated(0.46) | benign(0.005) | TCGA-B5-A0JY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD | |
COQ6 | SNV | Missense_Mutation | novel | c.975N>T | p.Lys325Asn | p.K325N | Q9Y2Z9 | protein_coding | tolerated(0.31) | benign(0.007) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
COQ6 | SNV | Missense_Mutation | novel | c.1097N>G | p.Asp366Gly | p.D366G | Q9Y2Z9 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |